Hos disse patienter, samt hos patienter med dekompenseret leversygdom, anbefales behandlingsophør ikke, og disse patienter bør overvåges nøje under behandlingen.
In these patients, including patients with decompensated liver disease, treatment cessation is not recommended and these patients should be monitored closely during therapy.